GB9414453D0 - New heterobicyclic derivatives - Google Patents

New heterobicyclic derivatives

Info

Publication number
GB9414453D0
GB9414453D0 GB9414453A GB9414453A GB9414453D0 GB 9414453 D0 GB9414453 D0 GB 9414453D0 GB 9414453 A GB9414453 A GB 9414453A GB 9414453 A GB9414453 A GB 9414453A GB 9414453 D0 GB9414453 D0 GB 9414453D0
Authority
GB
United Kingdom
Prior art keywords
heterobicyclic derivatives
new
new heterobicyclic
derivatives
heterobicyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9414453A
Other versions
GB2291422A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to GB9414453A priority Critical patent/GB2291422A/en
Publication of GB9414453D0 publication Critical patent/GB9414453D0/en
Publication of GB2291422A publication Critical patent/GB2291422A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9414453A 1994-07-18 1994-07-18 4-phenyl-pyrido[2,3-b]pyrazin-4-ones Withdrawn GB2291422A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9414453A GB2291422A (en) 1994-07-18 1994-07-18 4-phenyl-pyrido[2,3-b]pyrazin-4-ones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9414453A GB2291422A (en) 1994-07-18 1994-07-18 4-phenyl-pyrido[2,3-b]pyrazin-4-ones

Publications (2)

Publication Number Publication Date
GB9414453D0 true GB9414453D0 (en) 1994-09-07
GB2291422A GB2291422A (en) 1996-01-24

Family

ID=10758501

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9414453A Withdrawn GB2291422A (en) 1994-07-18 1994-07-18 4-phenyl-pyrido[2,3-b]pyrazin-4-ones

Country Status (1)

Country Link
GB (1) GB2291422A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721099C2 (en) * 1997-05-20 1999-12-02 Fumapharm Ag Muri Use of fumaric acid derivatives
DE19853487A1 (en) 1998-11-19 2000-05-25 Fumapharm Ag Muri Use of dialkyl fumarate for treating transplant rejection and autoimmune disease
US20040220103A1 (en) 1999-04-19 2004-11-04 Immunex Corporation Soluble tumor necrosis factor receptor treatment of medical disorders
WO2001087328A2 (en) 2000-05-12 2001-11-22 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
US7892563B2 (en) 2003-05-20 2011-02-22 Wyeth Holdings Corporation Methods for treatment of severe acute respiratory syndrome (SARS)
AU2004269903B2 (en) 2003-09-09 2010-09-02 Biogen International Gmbh The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
ES2916649T3 (en) 2007-02-08 2022-09-21 Biogen Ma Inc Compositions and uses for the treatment of multiple sclerosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008864A1 (en) * 1978-08-15 1980-03-19 FISONS plc Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
GB2291422A (en) 1996-01-24

Similar Documents

Publication Publication Date Title
HU9700358D0 (en) New oxazolidinon derivatives
ZA952413B (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
HUP9900684A3 (en) New 19-nor-pregnene derivatives
GB9511077D0 (en) 17B-Substituted-6-azasteroid derivatives
EP0708091A3 (en) Indoloylguanidine derivatives
ZA953356B (en) Benzocycloalkylazolethione derivatives
EP0692482A3 (en) 1-pyridyltetrazolinone derivatives
GB2295614B (en) Novel 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinylbenzimidazole derivatives
IL112519A0 (en) 5-heteroarylindole derivatives
ZA954125B (en) Novel dialkoxy-pyridinyl-benzimidazole derivatives
GB9414453D0 (en) New heterobicyclic derivatives
HU9503582D0 (en) Thienopyridon derivatives
GB9511365D0 (en) Pyridazino-indole derivatives
GB9405533D0 (en) Heterocyclic derivatives
GB2287463B (en) Bis-anthracycline derivatives
GB2291425B (en) 7-Diazo-beta-lactam derivatives
GB9322960D0 (en) New heterobicyclic derivatives
GB9416008D0 (en) New heterocyclic derivatives
GB9417443D0 (en) New heterocyclic derivatives
GB9409900D0 (en) New heterocyclic derivatives
GB9407018D0 (en) New heterocyclic derivatives
GB9409005D0 (en) Substituted azo-dicarbonylo derivatives
GB9410863D0 (en) Heterocyclycarbonyl substituted oxalylamino-benzofurane derivatives
GB9424295D0 (en) Heterocyclic derivatives
GB9421548D0 (en) Heterocyclic derivatives

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)